Mes compétences :
Gestion de projet
Cosmétique
Chimie
Coordination de projet
CAPA
GMP
Compliance
Deviations
Industrie pharmaceutique
Entreprises
GlaxoSmithKline
- Coordinator Compliance Team
Marly-le-Roi 2011 - maintenantCoordination of Deviations & CAPAs processes for Warehouse and Export departments.
The Warehouse and Export departments are involved in a close collaboration with all GSK Vaccines departments and need to be ready for inspection at any time. Nowadays, audits are strongly focused on Deviations and CAPAs quality and management.
In this context a support was needed to improve the Warehouse Deviations and CAPAs processes to face authorities growing quality expectations.
- Management of Deviations & CAPAs and review of existing processes to improve them
- Identification of new tools (KPI, check-lists, meetings…) to increase RFT and notifications quality
- Writing of a Deviations & CAPAs user guide and coaching of new supervisors on these processes
- Identify solutions to reduce incident reports for Warehouse Incoming Team
- Improvement of SOPs review processes particularly when linked to CAPAs
- Organization, lead and report writing of transversal meetings
Avertim
- Consultant
PARIS 82011 - maintenantAvertim is a unique Innovation and Management consulting group dedicated to building the bridge
between Strategy and Operations.
Our mission is to align Business, Technology and Management.
Avertim serves companies and organizations across various industries and sectors. Most of our consultants are senior professionals with strong industry, management and technological backgrounds dedicated to delivering the highest results.
Our values, unique culture and human organization are keys to making a lasting difference by sharing our experience and passion.
www.avertim.com
L'Oréal
- Research Engineer in metabolism - Life Science Department
PARIS2010 - 2010Set up of a metabolic stability platform for Metabolism Department to study compound’s efficacy, toxicity and stability.
In a context of reduction of both costs and time allowed for new molecules development, L’Oréal wanted to set up a platform which will enable the screening and selection of molecules developed by R&D. The selection would be based on molecules’ efficacy and toxicity results in order to put on the side molecules not adapted to a cosmetic use as soon as possible in the development path.
- Interaction with an external consultant and several laboratories of L’Oreal Advanced Research
- Project planification, purchase of raw materials and budget management (~12 K€)
- Protocols optimization and development of 15 methods in liquid chromatography paired with mass spectrometry in agreement with the FDA Guidance on bioanalytical methods
- Study of reference compounds metabolism and stability (half-life time - identification of metabolites)
Guerbet
- Research Engineer in Drug Discovery Department
Villepinte2009 - 2009Synthesis and characterization of Chemical Exchange Saturation Transfer agents for MRI
